NEO · MYCO.NE
Mydecine Innovations Group Inc.
CA$0.35CA$0.00 (0.0%)
Mydecine Innovations Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
Loading market information…
CNQ · BBM.CN · CAD
Stock price, earnings
Quote as of Oct 28, 2026, 12:44 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Blueberries Medical Corp.’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Blueberries Medical Corp.’s next earnings report is currently expected on Nov 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Blueberries Medical Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and its associated products across Colombia. Their offerings notably include medicinal cannabis oil extracts and other complementary items.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.35CA$0.00 (0.0%)
Mydecine Innovations Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.79CA$0.00 (0.0%)
Crescita Therapeutics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
CA$0.03CA$0.00 (0.0%)
Red Light Holland Corp.’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
CA$0.04-CA$0.02 (-27.27%)
Lobe Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
CA$0.04-CA$0.01 (-22.22%)
CLS Holdings USA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.16% below the high.
CA$0.03CA$0.00 (0.0%)
Christina Lake Cannabis Corp.’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
CA$0.06+CA$0.01 (+10.0%)
PharmaTher Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.63% below the high.
CA$0.02CA$0.00 (0.0%)
Nextleaf Solutions Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.43% below the high.
